BBIONasdaq United States
Market cap
$16.533 B
$84.48 +2.03%
Close of 7 Aug 2026
Revenue
$502.1M
#1908 by revenue
Earnings
—
Not reported
Shares outstanding
195,861,242
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for BridgeBio Pharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.